Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
240.50    5.00 (2.12%)
Bid:
239.00
Ask:
240.00
Spread: 1.00 (0.418%)
Market Cap: £1.43b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Board Changes

28 May 2021 10:15

RNS Number : 1920A
Mitchells & Butlers PLC
28 May 2021
 

28 May 2021

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

 

Board Changes

 

 

Mitchells & Butlers plc announces the following changes to its Board.

 

Ron Robson, who joined the Board in 2010, and is a nominated representative of the Group's largest shareholder, the Odyzean Group, Imelda Walsh, Chair of the Remuneration Committee, and Colin Rutherford, Chair of the Audit Committee, who both joined the Board in 2013, will all retire from the Board at the end of July 2021.

 

Following these changes , the Board of M&B will be comprised of the non-executive chairman, Bob Ivell, two executive directors (Phil Urban, CEO and Tim Jones, CFO), three independent non-executive directors (Susan Murray, who will remain as senior independent director, Jane Moriarty, who will assume the role of chair of the Audit Committee, and Dave Coplin, who will continue in his role as non-executive director nominated for representation of the "workforce voice") and three non-executive directors representing the interests of the Odyzean Group (Eddie Irwin, Josh Levy and Keith Browne).

 

An announcement in relation to the chairmanship of the Remuneration Committee is expected to be made in the next few months.

 

The office of Deputy Chairman currently held by Mr Robson will not be continued.

 

Commenting on these changes, chairman Bob Ivell said:

 

Ron, Imelda and Colin have provided excellent service to M&B throughout their time on the Board, helping to achieve a significant period of stability for the Company whilst assisting our governance and oversight arrangements.

 

We are extremely grateful to all three of these highly regarded non-executive directors for the support, guidance and enthusiasm which they have brought to the Board and everyone at M&B wishes them every success for the future.

 

In its prospectus issued on 22 February 2021, the Company confirmed that the Odyzean Group, which comprises shareholders with a majority of the shares in the Company, would review the composition of the Board to streamline its decision making and reduce the number of non-executive directors. By making these changes now, the smaller, more agile Board is in line with the Company's stated intentions at the time of the equity raise and it can now focus on supporting and challenging management over the coming months, as the business first recovers and then moves forward again.

 

We hope to make a further announcement in the near future in relation to the position of chair of the Remuneration Committee which should conclude this process.

 

For further information, please contact:

 

Greg McMahon

Company Secretary & General Counsel

0121 498 6514

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKFBPFBKKAPB
Date   Source Headline
18th May 20227:00 amRNSHalf Year Results
13th May 202211:00 amRNSNotice of Half Year Results
4th May 202210:00 amRNSDirector/PDMR Shareholding
29th Apr 202211:45 amRNSTotal Voting Rights
4th Apr 202212:15 pmRNSDirector/PDMR Shareholding
1st Apr 202211:45 amRNSBlock listing Interim Review
1st Apr 202211:00 amRNSTotal Voting Rights
8th Mar 202212:00 pmRNSDirector/PDMR Shareholding
4th Mar 202210:30 amRNSBoard Appointment
28th Feb 202211:27 amRNSTotal Voting Rights
7th Feb 20223:00 pmRNSDirector/PDMR Shareholding
31st Jan 20222:00 pmRNSTotal Voting Rights
25th Jan 20221:15 pmRNSResult of Annual General Meeting
13th Jan 20227:00 amRNSFirst Quarter Trading Update
12th Jan 202212:00 pmRNSNotice of first quarter trading update
10th Jan 20224:15 pmRNSDirector/PDMR Shareholding
31st Dec 202112:20 pmRNSTotal Voting Rights
23rd Dec 202112:20 pmRNSBoard Changes
23rd Dec 202112:00 pmRNSAnnual Report 2021
13th Dec 20213:30 pmRNSDirector/PDMR Shareholding
7th Dec 202110:00 amRNSDirector/PDMR Shareholding
30th Nov 20213:45 pmRNSTotal Voting Rights
29th Nov 20212:00 pmRNSDirector/PDMR Shareholding
25th Nov 20212:30 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSFull Year Results
22nd Nov 20212:30 pmRNSNotice of Final Results
15th Nov 202112:45 pmRNSDirector/PDMR Shareholding
29th Oct 20212:00 pmRNSTotal Voting Rights
18th Oct 20212:15 pmRNSDirector/PDMR Shareholding
1st Oct 20212:35 pmRNSBlock listing Interim Review
1st Oct 20212:30 pmRNSDirector/PDMR Shareholding
30th Sep 202110:43 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSPre-Close Trading Update
22nd Sep 20211:00 pmRNSNotice of Pre-Close Trading Statement
20th Sep 20212:00 pmRNSDirector/PDMR Shareholding
31st Aug 20212:15 pmRNSTotal Voting Rights
24th Aug 20211:30 pmRNSHolding(s) in Company
23rd Aug 20212:15 pmRNSDirector/PDMR Shareholding
30th Jul 20212:00 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSThird Quarter Trading Update
26th Jul 20212:15 pmRNSDirector/PDMR Shareholding
26th Jul 202112:00 pmRNSNotice of Third Quarter Trading Update
15th Jul 202110:00 amRNSBoard Changes update
7th Jul 202111:00 amRNSAdditional Listing
1st Jul 202111:00 amRNSTotal Voting Rights
28th Jun 202111:45 amRNSDirector/PDMR Shareholding
28th Jun 202111:30 amRNSAdditional Listing
18th Jun 202110:02 amRNSDirector/PDMR Shareholding
18th Jun 202110:00 amRNSDirector/PDMR Shareholding
1st Jun 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.